1. Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study. Issue 3 (27th May 2020) Authors: Mansour, Sam E; Kiernan, Daniel F; Roth, Daniel B; Eichenbaum, David; Holekamp, Nancy M; Kaba, Samer; Werts, Erica Journal: British journal of ophthalmology Issue: Volume 105:Issue 3(2021) Page Start: 414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗